Alnylam appoints tolga tanguler chief commercial officer and also announces new cemea, medical affairs, and compliance leaders

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, today announced the appointment of tolga tanguler to the role of chief commercial officer where he will lead global marketing, sales, market access, commercial operations, training, new product commercialization and commercial strategy for the company. tolga will also join the company's management board. in addition, alnylam has recruited an experienced team of leaders across
ALNY Ratings Summary
ALNY Quant Ranking